SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lahiri M, Morgan C, Symmons DP, Bruce IN.Modifiable risk factors for RA: prevention, better than cure?Rheumatology (Oxford)2012;51:499512.
  • 2
    Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, et al.Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.Ann Rheum Dis2010;69:5460.
  • 3
    Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, et al.Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.Ann Rheum Dis2010;69:7081.
  • 4
    Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR.Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis.Epidemiology1994;5:52532.
  • 5
    Symmons DP, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG, et al.Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care–based incident case–control study in Norfolk, England.Arthritis Rheum1997;40:195561.
  • 6
    Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M, et al.Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study.Am J Med2002;112:46571.
  • 7
    Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al.Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.Ann Rheum Dis2003;62:83541.
  • 8
    Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, et al.Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.Arthritis Res Ther2006;8:R133.
  • 9
    Costenbader KH, Feskanich D, Mandl LA, Karlson EW.Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.Am J Med2006;119:50311.
  • 10
    Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW.Geographic variation in rheumatoid arthritis incidence among women in the United States.Arch Intern Med2008;168:166470.
  • 11
    Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, et al.Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study.Environ Health Perspect2010;118:95761.
  • 12
    Hart JE, Laden F, Puett RC, Costenbader KH, Karlson EW.Exposure to traffic pollution and increased risk of rheumatoid arthritis.Environ Health Perspect2009;117:10659.
  • 13
    Sluis-Cremer GK, Hessel PA, Hnizdo E, Churchill AR.Relationship between silicosis and rheumatoid arthritis.Thorax1986;41:596601.
  • 14
    Stolt P, Kallberg H, Lundberg I, Sjogren B, Klareskog L, Alfredsson L.Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.Ann Rheum Dis2005;64:5826.
  • 15
    Sverdrup B, Kallberg H, Bengtsson C, Lundberg I, Padyukov L, Alfredsson L, et al.Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.Arthritis Res Ther2005;7:R1296303.
  • 16
    Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries RR, Cats A.Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption.Ann Rheum Dis1990;49:9802.
  • 17
    Cerhan JR, Saag KG, Criswell LA, Merlino LA, Mikuls TR.Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.J Rheumatol2002;29:24654.
  • 18
    Kallberg H, Jacobsen S, Bengtsson C, Pedersen M, Padyukov L, Garred P, et al.Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies.Ann Rheum Dis2009;68:2227.
  • 19
    Spector TD, Roman E, Silman AJ.The pill, parity, and rheumatoid arthritis.Arthritis Rheum1990;33:7829.
  • 20
    Romieu I, Hernandez-Avila M, Liang MH.Oral contraceptives and the risk of rheumatoid arthritis: a meta-analysis of a conflicting literature.Br J Rheumatol1989;28 Suppl:1323.
  • 21
    Spector TD, Hochberg MC.The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis.J Clin Epidemiol1990;43:122130.
  • 22
    Pladevall-Vila M, Delclos GL, Varas C, Guyer H, Brugues-Tarradellas J, Anglada-Arisa A.Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity.Am J Epidemiol1996;144:114.
  • 23
    Jorgensen C, Picot MC, Bologna C, Sany J.Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.Ann Rheum Dis1996;55:948.
  • 24
    Karlson EW, Mandl LA, Hankinson SE, Grodstein F.Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study.Arthritis Rheum2004;50:345867.
  • 25
    Doran MF, Crowson CS, O'Fallon WM, Gabriel SE.The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.J Rheumatol2004;31:20713.
  • 26
    Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, et al, for the Women's Health Initiative Investigators.Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Women's Health Initiative randomized controlled trials.Arthritis Rheum2008;59:30210.
  • 27
    Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Berglund G, Turesson C.Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis.Ann Rheum Dis2009;68:52630.
  • 28
    Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Turesson C.Early menopause is an independent predictor of rheumatoid arthritis.Ann Rheum Dis2012;71:37881.
  • 29
    Olsson AR, Skogh T, Wingren G.Aetiological factors of importance for the development of rheumatoid arthritis.Scand J Rheumatol2004;33:3006.
  • 30
    Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L.Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.Ann Rheum Dis2005;64:158894.
  • 31
    Pedersen M, Jacobsen S, Klarlund M, Frisch M.Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study.J Rheumatol2006;33:106974.
  • 32
    Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al.Defining the role of the MHC in autoimmunity: a review and pooled analysis.PLoS Genet2008;4:e1000024.
  • 33
    Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al.A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.Am J Hum Genet2004;75:3307.
  • 34
    Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, Maller J, et al.Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.Nat Genet2007;39:147782.
  • 35
    Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al.STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.N Engl J Med2007;357:97786.
  • 36
    Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al.TRAF1–C5 as a risk locus for rheumatoid arthritis: a genomewide study.N Engl J Med2007;357:1199209.
  • 37
    Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, et al.Common variants at CD40 and other loci confer risk of rheumatoid arthritis.Nat Genet2008;40:121623.
  • 38
    Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, et al.Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.Nat Genet2009;41:13138.
  • 39
    Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al.Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.Nat Genet2010;42:50814.
  • 40
    Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L, for the Epidemiological Investigation of Rheumatoid Arthritis Study Group.A gene–environment interaction between smoking and shared epitope genes in HLA–DR provides a high risk of seropositive rheumatoid arthritis.Arthritis Rheum2004;50:308592.
  • 41
    Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al, and the Epidemiological Investigation of Rheumatoid Arthritis Study Group.A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination.Arthritis Rheum2006;54:3846.
  • 42
    Keenan BT, Chibnik LB, Cui J, Ding B, Padyukov L, Kallberg H, et al.Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis.Arthritis Rheum2010;62:3196210.
  • 43
    Kannel WB.The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.J Gend Specif Med2002;5:2737.
  • 44
    Avins AL, Browner WS.Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes.JAMA1998;279:4459.
  • 45
    Sytkowski PA, Kannel WB, D'Agostino RB.Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study.N Engl J Med1990;322:163541.
  • 46
    Deane KD, Norris JM, Holers VM.Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation.Rheum Dis Clin North Am2010;36:21341.
  • 47
    Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz JN, et al.A connective tissue disease screening questionnaire for population studies.Ann Epidemiol1995;5:297302.
  • 48
    Karlson EW, Chibnik LB, Tworoger SS, Lee IM, Buring JE, Shadick NA, et al.Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.Arthritis Rheum2009;60:64152.
  • 49
    Gabriel SE, Crowson CS, O'Fallon WM.The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985.Arthritis Rheum1999;42:41520.
  • 50
    Karlson EW, Chibnik LB, Kraft P, Cui J, Keenan BT, Ding B, et al.Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.Ann Rheum Dis2010;69:107785.
  • 51
    Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, Group G.Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement.Genet Med2011;13:4536.
  • 52
    Nagelkerke N.A note on a general definition of the coefficient of determination.Biometrika1991;78:6912.
  • 53
    Lemeshow S, Hosmer DW Jr.A review of goodness of fit statistics for use in the development of logistic regression models.Am J Epidemiol1982;115:92106.
  • 54
    Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS.Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.Stat Med2008;27:15772.
  • 55
    Pencina MJ, D'Agostino RB Sr, Steyerberg EW.Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.Stat Med2011;30:1121.
  • 56
    Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, Czernichow S, et al.Predicting diabetes: clinical, biological, and genetic approaches. Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).Diabetes Care2008;31:205661.
  • 57
    De Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, Grant RW, et al.Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.Diabetes Care2011;34:1215.
  • 58
    Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, et al.Clinical risk factors, DNA variants, and the development of type 2 diabetes.N Engl J Med2008;359:222032.
  • 59
    Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al.Genotype score in addition to common risk factors for prediction of type 2 diabetes.N Engl J Med2008;359:220819.
  • 60
    Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, et al.Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.BMJ Clin Res Ed2010;340:b4838.
  • 61
    Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, et al.Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.Nat Genet2009;41:4755.
  • 62
    Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM.Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.Ann Intern Med2009;150:6572.
  • 63
    Willems SM, Mihaescu R, Sijbrands EJ, van Duijn CM, Janssens AC.A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research.Curr Diab Rep2011;11:5118.
  • 64
    Aschard H, Chen J, Cornelis MC, Chibnik LB, Karlson EW, Kraft P.Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases.Am J Hum Genet2012;90:96272.
  • 65
    Van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, et al.Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.Arthritis Rheum2007;56:142432.
  • 66
    Verstappen SM, McCoy MJ, Roberts C, Dale NE, Hassell AB, Symmons DP.Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.Ann Rheum Dis2010;69:5039.
  • 67
    Cook NR.Use and misuse of the receiver operating characteristic curve in risk prediction.Circulation2007;115:92835.
  • 68
    Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P.Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.Am J Epidemiol2004;159:88290.
  • 69
    Ridker PM, Buring JE, Rifai N, Cook NR.Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.JAMA2007;297:6119.
  • 70
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al.Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.Arthritis Rheum2003;48:27419.
  • 71
    Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al.Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.Arthritis Rheum2004;50:3806.
  • 72
    Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW.Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis.J Rheumatol2009;36:70611.
  • 73
    Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S.Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis.Arthritis Rheum2010;62:38391.
  • 74
    Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, et al.Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.PLoS One2012;7:e35296.
  • 75
    Cook NR.Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.Clin Chem2008;54:1723.